Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Crispr Therapeutics Ag

Clinical trials sponsored by Crispr Therapeutics Ag, explained in plain language.

CRISPR Therapeutics AG CRSP NASDAQ

Gene-editing biotech developing CRISPR-based therapies.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 4 Completed 1 Terminated 2

Gene-Edited immune cells take on Hard-to-Treat cancers

Disease control Completed

This early-phase trial tested a new treatment called CTX131 for adults with advanced solid tumors that have not responded to standard therapies. The treatment uses donor immune cells that are gene-edited to target a protein called CD70 found on cancer cells. The study enrolled 19…

Phase: PHASE1, PHASE2 • Sponsor: CRISPR Therapeutics AG • Aim: Disease control

Last updated Jun 27, 2026 08:00 UTC